Post

New research · Oncology
Digital health · 23h
AI / informaticsDigital health · 2026

Predicting cancer treatment outcomes using machine learning enabled clinical decision support systems.

Adib Hossain, Md Mohaimin Rashid, Towsif Alam … Mst Rina Parvin
Read paper
OncologyAI / informatics

A review identified 32 studies on machine learning for cancer outcome prediction.

Predicting cancer treatment outcomes using machine learning enabled clinical decision support systems.

Adib Hossain et al. · Digital health · 2026
Background

Cancer treatment poses significant challenges due to variability in patient responses, disease progression, and therapy outcomes.

Purpose

This scoping review aimed to explore how ML-powered CDSS are applied to predict treatment outcomes across different types of cancer.

Methods

A systematic search was conducted across six databases covering studies from 2010 to 2025.

n = 32 studies
Results
studies exploring machine learning to predict cancer outcomes
n = 32 studies
More results

Predictive objectives ranged from survival estimation and therapy response to toxicity risk and recurrence detection.

ML techniques varied from decision trees and vector machines to deep learning models such as convolutional neural networks.

More results

While technical performance was promising, few studies demonstrated external validation or integration into clinical workflows.

Interpretability, ethical considerations, and patient involvement were frequently underreported.

“
Conclusion · 1 of 2

ML-enabled CDSS have shown significant potential in predicting cancer treatment outcomes, yet their adoption in practice remains limited.

Conclusion · 2 of 2

Advancing these systems requires focus on validation, interpretability, data integration, and ethical design to bridge the gap between innovation and clinical utility.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
1.16%
Safety Agent gating reduced incorrect patient inclusion to 1.16% for non-small cell lung cancer trials.
Randomized Trial
HR 0·45
switching to camizestrant significantly lowered the chance of cancer worsening or death
Randomized Trial
HR 0·38
the drug combination significantly reduced the chance of cancer progression or death
Observational
16.3%
breast cancer was the largest percentage of all recorded cancer cases
Cohort Study
adjusted odds ratio 2.45
emergency surgery means over twice the risk of cancer cells left behind
Cohort Study
OR=3.48
immediate reconstruction is associated with higher odds of short-term complications
AI / Informatics
AUC = 0.939
This shows the model's excellent ability to predict ovarian cancer treatment response
Guideline
22 items
the new checklist for bladder tumor surgery has 22 elements to standardize care